AZB & Partners advised Meta Platforms on its USD 900 million investment in CRED (Dreamplug Technologies Private Limited), handling the transaction from due diligence to closing. The deal included primary and secondary investments, marking a major corporate and startup funding milestone.
Representing JSW Energy and JSW Steel, Cyril Amarchand Mangaldas secured a significant Karnataka High Court ruling quashing KERC’s captive status verification procedure. The judgment provides major relief to captive power users and reinforces the regulatory framework governing captive power projects.
Cosmic PV Power Limited plans a Rs.640 crore IPO, featuring a Rs.540 crore fresh issue and a Rs.100 crore OFS by promoters and investors. CMS INDUSLAW is advising the company on the public issue as it moves forward.
The CCPA has fined Meesho Rs 10 lakh for allowing the sale of walkie-talkies without essential legal and compliance disclosures. The watchdog said the platform misled consumers and failed to prevent the listing of restricted radio devices.
The central government has formed a high-level multi-disciplinary committee to investigate the tragic crash of Air India Flight AI-171, which occurred shortly after takeoff from Ahmedabad en route to London.
Today, On 27th November, Gautam Adani and several executives from Adani Green faced allegations of securities law violations related to a bribery scheme in India. The U.S. SEC’s complaints and criminal indictments indicate serious legal challenges for the Adani Group, leading to significant financial losses and declines in stock prices for Adani Green.
Today(on 4th July), Chief Justice of India D Y Chandrachud urged SEBI and SAT to exercise caution in the face of surging equity markets, highlighting the need for additional tribunal benches to stabilize operations. He emphasized the pivotal role of regulatory bodies in maintaining market stability and stressed the urgency of addressing the increased workload and pending appeals at SAT.
On Wednesday (10th April): The Supreme Court of India expressed concern for public well-being, particularly regarding misleading advertisements and unregulated products. Justices emphasized that violations of the law, such as exploiting people’s trust with misleading claims, will not be tolerated. This relates to a recent contempt plea against Patanjali for marketing its product, Coronil, as a COVID-19 cure, violating drug advertising regulations.
